Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer

Author： Koukourakis George   Baksevanis Constantinos   Zambatis Haralambos   Gritzapis Angelos   Maltezos Efstratios   Simopoulos Costantinos   Koukourakis Michael  

Publisher： Informa Healthcare

ISSN： 1362-3095

Source： International Journal of Radiation Biology, Vol.85, Iss.1, 2009-01, pp. : 96-104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral candidiasis in head and neck cancer patients receiving radiotherapy with amifostine cytoprotection

By Nicolatou-Galitis O.   Sotiropoulou-Lontou A.   Velegraki A.   Pissakas G.   Kolitsi G.   Kyprianou K.   Kouloulias V.   Papanikolaou I.   Yiotakis I.   Dardoufas K.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 397-401

Elsevier

Access to resources Recommend Favorite

Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer

By                    

International Journal of Oncology, Vol. 40, Iss. 3, 2012-01 ,pp. : 645-654

Spandidos Publications

Access to resources Recommend Favorite

Lipid Rafts and Fas/CD95 Signaling in Cancer Chemotherapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 274-283

Bentham Science Publishers

Access to resources Recommend Favorite

Radiotherapy for head and neck cancer in elderly patients

By Schofield C.P.   Sykes A.J.   Slevin N.J.   Rashid N.Z.Z.  

Radiotherapy and Oncology, Vol. 69, Iss. 1, 2003-10 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite

Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients

By Malouf J.G.   Aragon C.   Henson B.S.   Eisbruch A.   Ship J.A.  

Cancer Detection and Prevention, Vol. 27, Iss. 4, 2003-01 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite